ERS 2023: Aerosol Delivery During High Flow Nasal Oxygenation: Breath-Enhanced Nebulization
In the present study, researchers explored the effectiveness of breath-enhanced jet nebulization (BEJN) compared to a conventional mesh nebulizer (VMN) when used in conjunction with high-flow nasal cannula (HFNC) systems. They employed a 3D-printed nasal/head model connected to a high-flow nasal cannula and subjected it to "distressed" ventilation conditions. Real-time measurement of radiolabelled aerosol delivery was carried out using a shielded ratemeter. The results indicated that BEJN achieved maximum aerosol output at an infusion rate of 50 mL/h, whereas VMN reached its peak at 12 mL/h. Despite significant aerosol losses within the system, BEJN demonstrated 3-5 times greater drug delivery to the trachea compared to VMN. Additionally, BEJN allowed for a wide range of infusion flow rates, enabling titration of drug delivery over a broad spectrum. At the highest gas flow of 60 L/min, BEJN's aerosol delivery varied considerably, providing a potential for individualized treatment in critically ill patients. In conclusion, BEJN effectively utilized high nasal cannula gas flow to enhance nebulizer output, offering the possibility of tailored treatments based on clinical responses by adjusting infusion rates.
Poster ID 3609, European Respiratory Society (ERS) International Congress 2023, Milan, Italy, 9-13 September 2023.


